RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Clinical trial NCT06154252 · RECRUITING

Trial details

NCT number: NCT06154252
Sponsor: Cabaletta Bio
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Idiopathic Inflammatory Myopathy Dermatomyositis Anti-Synthetase Syndrome Immune-Mediated Necrotizing Myopathy Juvenile Dermatomyositis Juvenile Polymyositis Juvenile Idiopathic Inflammatory Myopathy (JIIM)Juvenile Myositis

Start date: 2023-12-20
Primary completion: 2028-07-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.